Our data show for the first time MCs as a new source for ET-1 in the ovarian cancer TME, which can act as an autocrine factor and can cooperate with tumor-derived ET-1, to drive MC proliferation and cancer-associated MC behaviour. Here, EDN1 is linked to neoplasm.